MRI Labeling For Boston Scientific's Emblem MRI S-ICD Approved By US FDA

Boston Scientific cardiac rhythm management has been struggling to compete with MRI-compatible devices from rival Medtronic.

US FDA's approval of Boston Scientific Corp.'s Emblem MRI S-ICD subcutaneous implantable defibrillator, announced Aug. 9, is the latest in a string of approvals of ImageReady magnetic resonance imaging-compatible devices that should help the company become more competitive in the cardiac rhythm management market.

Emblem MRI S-ICD, which earned a CE mark in April, is an MR-compatible version of the Emblem S-ICD. (Also see "APPROVALS ANALYSIS: Big Month For Cardio Devices, But Down...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from R&D

More from Business